Treating chronic constipation: How should we interpret the recommendations?

Clinical Drug Investigation

Volumn 26, Issue 10, 2006, Pages 547-557

  Johnson, David A ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALTREXONE; ALVIMOPAN; ANTHRAQUINONE; BISACODYL; BULKING AGENT; DOCUSATE CALCIUM; DOCUSATE SODIUM; GLYCEROL; LACTULOSE; LAXATIVE; LUBIPROSTONE; MACROGOL; MAGNESIUM CITRATE; MAGNESIUM HYDROXIDE; MAGNESIUM SULFATE; METHYLCELLULOSE; NEUTROPHIN 3; OPIATE ANTAGONIST; OSMOTIC AGENT; PLACEBO; SENNA EXTRACT; SEROTONIN AGONIST; SODIUM CHLORIDE; SODIUM DIHYDROGEN PHOSPHATE; SODIUM SULPHATE; SORBITOL; TEGASEROD; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ABDOMINAL PAIN; BLOATING; CLINICAL PRACTICE; COLON OBSTRUCTION; CONSTIPATION; DIARRHEA; DISORDERS OF CARBOHYDRATE METABOLISM; DRUG ABUSE; DRUG MECHANISM; ELECTROLYTE DISTURBANCE; ESOPHAGUS OBSTRUCTION; FECES; FEEDBACK SYSTEM; HEADACHE; HUMAN; HYPERMAGNESEMIA; HYPERPHOSPHATEMIA; HYPOKALEMIA; HYPONATREMIA; IRON METABOLISM DISORDER; LIFESTYLE; MUSCLE CRAMP; NAUSEA; PATIENT; PATIENT CODING; PELVIC ORGAN PROLAPSE; PERISTALSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STOMACH DISEASE; SYMPTOM; THROAT IRRITATION; TREATMENT INDICATION; URTICARIA;

CHRONIC DISEASE; CONSTIPATION; HUMANS; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC;

EID: 33748799429     PISSN: 11732563     EISSN: 11732563     Source Type: Journal    
DOI: 10.2165/00044011-200626100-00001     Document Type: Review

References (45)

1. Dennison C, Prasad M, Lloyd A, et al. The health-related quality of life and economic burden of constipation. Pharmacoeconomics 2005; 23 (5): 461-76
2. Glia A, Lindberg G. Quality of life in patients with different types of functional constipation. Scand J Gastroenterol 1997 Nov; 32 (11): 1083-9
3. American College of Gastroenterology Chronic Constipation Task Force. An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol 2005; 100: S1-4
4. Brandt LJ, Prather CM, Quigley EMM, et al. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol 2005 Jul; 100: S5-22
5. Locke III GR, Pemberton JH, Phillips SF. American Gastroenterological Association Medical Position Statement: guidelines on constipation. Gastroenterology 2000 Dec; 119 (6): 1761-6
6. Locke III GR, Pemberton JH, Phillips SF. AGA technical review on constipation. Gastroenterology 2000 Dec; 119 (6): 1766-78
7. WGO-OMGE Practice Guideline: Constipation. World Organisation of Gastroenterology [online]. Available from URL: http://www.omge.org/ globalguidelines/guide04/guideline4.htm [Accessed 2006 Jul 27]
8. National Guideline Clearinghouse [online]. Available from http://www.guideline.gov [Accessed 2006 Aug 30]
9. Muller-Lissner SA, Kamm MA, Scarpignato C, et al. Myths and misconceptions about chronic constipation. Am J Gastroenterol 2005 Jan; 100 (1): 232-42
10. Talley NJ. Definitions, epidemiology, and impact of chronic constipation. Rev Gastroenterol Disord 2004; 4 Suppl. 2: S3-10
11. Pare P, Ferrazzi S, Thompson WG, et al. An epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol 2001; 96 (11): 3130-7
12. Herz MJ, Kahan E, Zalevski S, et al. Constipation: a different entity for patients and doctors. Fam Pract 1996 Apr; 13 (2): 156-9
13. Heaton KW, Radvan J, Cripps H, et al. Defecation frequency and timing, and stool form in the general population: a prospective study. Gut 1992 Jun; 33 (6): 818-24
14. Sandler RS, Drossman DA. Bowel habits in young adults not seeking health care. Dig Dis Sci 1987 Aug; 32 (8): 841-5
15. Thompson WG. Functional bowel disorders and functional abdominal pain. In: Drossman DA, Richter JE, Talley NJ, editors. The functional gastrointestinal disorders: diagnosis, pathophysiology, and treatment. McLean (VA): Degnon Associates, 1994: 115-73
16. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999 Sep; 45: II43-7
17. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006 May; 130: 1480-91
18. Dorland's medical dictionary. 30th ed. Philadelphia (PA): WB Saunders Co., 2003
19. Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 2004 Apr; 99 (4): 750-9
20. Chinese Society of Gastroenterology, Chinese Medical Association. Consensus on the guidelines for the diagnosis and treatment of chronic constipation. Chin J Dig Dis 2004; 5 (3): 134-7
21. Arce DA, Ermocilla CA, Costa H. Evaluation of constipation. Am Fam Physician 2002 Jun 1; 65 (11): 2283-90
22. Borum ML. Constipation: evaluation and management. Prim Care 2001; 28 (3): 577-90
23. Lembo A, Camilleri M. Chronic constipation. N Engl J Med 2003 Oct 2; 349 (14): 1360-8
24. Rao SS. Constipation: evaluation and treatment. Gastroenterol Clin North Am 2003 Jun; 32 (2): 659-83
25. Mertz H, Naliboff B, Mayer E. Physiology of refractory chronic constipation. Am J Gastroenterol 1999; 94 (3): 609-15
26. Bassotti G, Chistolini F, Sietchiping-Nzepa F, et al. Biofeedback for pelvic floor dysfunction in constipation. BMJ 2004 Feb 14; 328 (7436): 393-6
27. Enck P. Biofeedback training in disordered defecation: a critical review. Dig Dis Sci 1993 Nov; 38 (11): 1953-60
28. Rao SS, Enck P, Loening-Baucke V. Biofeedback therapy for defecation disorders. Dig Dis 1997; 15 Suppl. 1: 78-92
29. Heymen S, Jones KR, Scarlett Y, et al. Biofeedback treatment of constipation: a critical review. Dis Colon Rectum 2003 Sep; 46 (9): 1208-17
30. Annells M, Koch T. Constipation and the preached trio: diet, fluid intake, exercise. Int J Nurs Stud 2003 Nov; 40 (8): 843-52
31. Evans JM, Fleming KC, Talley NJ, et al. Relation of colonic transit to functional bowel disease in older people: a population-based study. J Am Geriatr Soc 1998; 46 (1): 83-7
32. Meshkinpour H, Selod S, Movahedi H, et al. Effects of regular exercise in management of chronic idiopathic constipation. Dig Dis Sci 1998 Nov; 43 (11): 2379-83
33. Fritz E, Hammer HF, Lipp RW, et al. Effects of lactulose and polyethylene glycol on colonic transit. Aliment Pharmacol Ther 2005 Feb 1; 21 (3): 259-68
34. MiraLax (polyethylene glycol 3550) [prescribing information]. Braintree (MA): Braintree Laboratories Inc., 2003
35. Pampati V, Fogel R. Treatment options for primary constipation. Curr Treat Options Gastroenterol 2004 Jun; 7 (3): 225-33
36. Jones MP, Talley NJ, Nuyts G, et al. Lack of objective evidence of efficacy of laxatives in chronic constipation. Dig Dis Sci 2002 Oct; 47 (10): 2222-30
37. Ramkumar D, Rao SSC. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol 2005 Apr; 100 (4): 936-71
38. Johanson JF, Wald A, Tougas G, et al. Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial. Clin Gastroenterol Hepatol 2004 Sep; 2 (9): 796-805
39. Kamm MA, Muller-Lissner S, Talley NJ, et al. Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol 2005 Feb; 100 (2): 362-72
40. Amitiza (lubiprostone) soft gelatin capsules [prescribing information]. Bethesda (MD): Sucampo Pharmaceuticals Inc., 2006
41. Johanson JF, Gargano MA, Holland PC, et al. Phase III efficacy and safety of RU-0211, a novel chloride channel activator, for the treatment of constipation [abstract]. Gastroenterology 2003; 124: A104
42. Johanson JF, Gargano MA, Holland PC, et al. Phase III study of lubiprostone, a chloride channel-2 (CIC-2) activator for the treatment of constipation: safety and primary efficacy [abstract]. Am J Gastroenterol 2005; 100 (9): S328-9
43. Zelnorm® (tegaserod maleate) tablets [prescribing information]. East Hanover (NJ): Novartis Pharmaceuticals Corporation, 2004
44. Schiller LR. New and emerging treatment options for chronic constipation. Rev Gastroenterol Disord 2004; 4: S43-51
45. Medoff J, Katz S, Malik P, et al. Open-label, dose-ranging pilot study of 4 weeks of low-dose therapy with sodium phosphate tablets in chronically constipated adults. Clin Ther 2004; 26 (9): 1479-91